The study was funded by the National Institute on Alcohol Abuse and Alcoholism, not a pharmaceutical company
Consider Trulicity if you prioritize tolerability and minimal GI disruption over maximum weight loss, or if previous attempts with higher-potency GLP-1 agonists caused side effects you wish to avoid
As with many emerging medical interventions, athletes, coaches, agents, physicians and performance staff are asking questions about their potential benefits and risks. The growing interest has caught the attention of watchdogs, too
Understanding the why behind each stepfrom reconstitution to administrationis what separates sloppy work from breakthrough data
This evidence-backed guide ranks the healthiest and least healthy fas
Disclaimer: This article is for informational purposes only and does not constitute medical advice